Gil Cohen
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Gil Cohen is currently the Vice President-Research & Development at Epitomee Medical Ltd. He previously worked as the Chief Science Officer at Dune Medical Devices Ltd. Dr. Cohen holds a doctorate degree from The Hebrew University of Jerusalem.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EPITOMEE MEDICAL LTD -.--% | 14-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EPITOMEE MEDICAL LTD | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops real-time cancer detection tools | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops real-time cancer detection tools | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epitomee Medical Ltd.
Epitomee Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medical devices for obesity | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau